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Abstract
Objective—To assess perception and behavior after reproductive health counseling among 
adolescent patients in a tertiary care-based pediatric rheumatology clinic.
Methods—Adolescent females seen at Stanford pediatric rheumatology clinic were prospectively 
enrolled during routine visits. At study start, standard clinic procedures for the following were 
reviewed with providers: 1) HEADSS (home, education, activities, drugs, sexual activity, and 
suicide/depression) assessment; 2) reproductive health counseling; and 3) medical record 
documentation. Patients were enrolled if providers indicated that they performed HEADSS 
assessment and reproductive health counseling. At enrollment, patients completed a survey to 
assess perceptions of reproductive health counseling. Chart review confirmed documented 
discussions. Follow-up survey 3-5 months after enrollment tracked reproductive health 
information seeking behavior.
Results—Ninety females (ages 17 ± 2 years old) participated. Almost all patients (99%) agreed 
that reproductive health was discussed. Seventy-one percent reported that pregnancy risks were 
discussed, 42% had recent concerns about reproductive health, and 33% reported their provider 
recommended that they seek further reproductive health care. Eighty-four patients completed 
follow-up phone surveys, with 25% reporting seeking further information on reproductive health 
concerns but merely 9.5% actually sought further care. Only 18% reported having ever asked their 
rheumatology provider for guidance regarding reproductive health care concerns.
Corresponding author: Tova Ronis, MDCM Rheumatology 111 Michigan Ave NW Washington, DC 20005 Phone: 202-476-6201 
Fax: 202-476-2280 tronis@cnmc.org. 
Author Contributions
All authors were involved in drafting the article or revising it critically for important intellectual content, and all authors approved the 
final version to be submitted for publication. Dr. Ronis had full access to all of the data in the study and takes responsibility for the 
integrity of the data and the accuracy of the data analysis. Study conception and design. Ronis, Frankovich, Yen, Sandborg, Chira. 
Acquisition of data. Ronis.
Analysis and interpretation of data. Ronis, Frankovich, Chira.
HHS Public Access
Author manuscript
Arthritis Care Res (Hoboken). Author manuscript; available in PMC 2015 March 10.
Published in final edited form as:
Arthritis Care Res (Hoboken). 2014 April ; 66(4): 631–635. doi:10.1002/acr.22159.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Conclusion—Routine reproductive health discussion and counseling are necessary in a 
rheumatology clinic; as in our experience, a substantial number of adolescents have concerns and 
actively seek reproductive health information. Despite these discussions, teens rarely pursued 
further reproductive health care. Further work to bridge this gap is needed.
Introduction
Adolescence is a unique period of rapid biological, social, emotional, and intellectual 
growth1. The psychosocial developmental process can be especially challenging for 
adolescents with chronic rheumatic diseases as they are encouraged to achieve self-care and 
independence, potentially causing conflict between teens and providers. For instance, 
adolescents may refuse medications with cosmetic effects despite understanding the benefits 
of treatment, or parents and providers may be unwilling to relinquish control of care to the 
adolescent for fear of adverse consequences. During this time many teens exhibit the 
impulsive decision-making of childhood, while experimenting with risky behaviors and not 
adhering to therapy2.
Typical adolescent behaviors can include unsafe sexual practices. The 2011 National Youth 
Risk Behavior Surveillance of high school students conducted by the Centers for Disease 
Control showed that 46% of high school females had ever had sex, 46% of sexually active 
females had not used a condom during their last sexual intercourse, and 78% of sexually 
active females did not use hormonal contraception before their last sexual intercourse3. 
These behaviors can have negative outcomes such as sexually transmitted infections and 
unplanned pregnancies, and the United States has the highest teen pregnancy rate of any 
developed country (estimated 400,000 teens aged 15-19 giving birth annually)4. Teen 
mothers are more likely to receive late or no prenatal care, have a preterm or low 
birthweight infant, and experience negative social outcomes, including school dropout4,5. 
Pregnancy rate data among adolescent rheumatology patients are lacking but unprotected 
sexual activity is a recognized clinical problem. Yearly screening of adolescent sexual health 
is recommended by the American Academy of Pediatrics (AAP) and American Medical 
Association (AMA) and is a quality measure for optimal care of patients with Juvenile 
Idiopathic Arthritis (JIA)6–8.
Pediatric rheumatology patients often take teratogenic or cytotoxic medications (e.g., 
methotrexate, leflunomide, mycophenolate mofetil, and cyclophosphamide,) contraindicated 
during pregnancy. Some rheumatic diseases (such as lupus) are reportedly more severe in 
adolescence with higher frequency of aggressive renal disease, requiring steroids and 
cytotoxic drugs9. Should unplanned pregnancy arise, the teen is typically advised to stop 
these medications to decrease risks to the developing fetus. Unfortunately, discontinuation 
of medicines and/or pregnancy itself can cause disease flare. Patients with active disease are 
more likely to have complications with pregnancy such as spontaneous abortion, intrauterine 
growth restriction, or preterm delivery10, compounding the risks of adolescent pregnancy.
Women aged 18-45 felt counseling regarding potential teratogenic risks of medications 
should occur when the medication is prescribed11. Since pediatric rheumatologists often see 
adolescents more frequently than their primary care physicians and are the prescribers of 
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these medications, the rheumatology clinic visit represents an important opportunity to 
effectively screen, counsel, and promote good reproductive health to prevent adverse 
pregnancy outcomes. Research on reproductive health in pediatric rheumatology patients has 
been limited with one study demonstrating physician screening practices could be improved 
with an educational intervention12.
No study has reported the correlation between adolescents’ perception about reproductive 
health screening and recommendations and physician documentation of this assessment, but 
literature has shown that physicians and adult patients often give discrepant reports about the 
events during a clinic visit13. Factors leading adolescents to seek further information and 
care regarding reproductive health have not been evaluated. The quality, effectiveness, and 
outcomes of reproductive health counseling have been challenging to assess14.
The goal of this study is to assess adolescent rheumatology patients’ perception and 
behavior after reproductive health counseling in the rheumatology clinic. Our overall 
objective is to foster positive reproductive health outcomes among adolescents with 
rheumatic diseases by improving reproductive health counseling in the pediatric 
rheumatology clinic.
Materials and Methods
Study population
A convenience sample of consecutive patients were invited to participate in the study if they 
met the following inclusion criteria: female sex, age 13-20 years, English speaking, 
diagnosis of a rheumatologic condition, >2 rheumatology clinic visits at Lucile Packard 
Children's Hospital at Stanford, and provider indication that the patient had received the 
routine reproductive health screening and counseling during the visit on enrollment day. IRB 
approval was obtained and all patients and at least one parent/guardian assented/consented 
to participate.
Reproductive health screening and counseling
Prior to study start, all clinic providers were instructed in the use of the HEADSS 
assessment, counseling tool, and medical record documentation and were encouraged to 
follow these standard clinic practice guidelines and documentation practices for all pediatric 
rheumatology patients. HEADSS is a psychosocial risk assessment instrument that has been 
in clinical use since 1974 and is a mnemonic for home, education, activities, drugs, sexual 
activity, and suicide/depression. It addresses the major areas of adolescent psychosocial 
stress and is a practical clinical screening instrument15. We developed a standardized clinic 
counseling tool that addressed topics of confidentiality, pregnancy risk in the context of the 
rheumatic disease, teratogenic risks of medications, contraception, and referral to 
reproductive health services (Table 1.) Eligible patients were screened and counseled with a 
paper HEADSS assessment and counseling tool that was included in the medical record by 
the rheumatology provider as part of their routine clinic visit.
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Data Collection and Presentation
Patients completed a questionnaire in clinic, directly after enrollment, on the day of the 
reproductive health screening and counseling. The initial questionnaire assessed patient-
provider trust, patient's perceptions of whether counseling had occurred, their general 
knowledge about medications and disease and whether the patient had recent reproductive 
health concerns. Follow-up phone surveys occurred 3-5 months after the initial enrollment 
and assessed whether the patient had sought further reproductive health information or care 
and their perception of talking about reproductive health with the rheumatologist. Charts 
were reviewed for demographic and medical data as well as for documentation of 
reproductive health screening. All questionnaires were pilot-tested to ensure that language 
was appropriate and understandable. Data are presented descriptively.
Results
Ninety patients were enrolled and completed an initial survey (from December 2010 -March 
2011.) All 90 participants had a rheumatologic disease, and 15 (17%) had a concurrent pain 
syndrome. Patient diagnoses, medication use, and demographic data are included in Table 2. 
Ninety-four percent had documentation of reproductive health counseling in the medical 
record.
Of the 90 patients enrolled, 23 (26%) had engaged in sexual intercourse and 3 (3%) were 
considering sexual activity. Eleven (12%) were already followed by another provider for 
reproductive health care. Almost all patients (99%) agreed reproductive health was 
discussed and 88 (98%) felt confidentiality was assured. Sixty-four patients (71%) reported 
that pregnancy risks of medications were discussed. All patients agreed they felt comfortable 
enough with the provider to ask questions. Eighty-eight patients (98%) understood the need 
to take medications for disease control. Almost half (38 patients, 42%) had recent concerns 
about reproductive health (which included pregnancy, sexually transmitted infections, or 
contraception issues.)
One third of the patients (30 patients, 33%) reported their provider recommended that they 
seek further reproductive health care. Of those patients who were recommended by their 
provider to seek further reproductive care, 10 (33%) were already followed by another 
provider for reproductive health care, 2 (6.7%) said they would definitely go, 12 (40%) 
planned to go in the future, 5 (17%) were noncommittal and 1 (3%) did not answer. See 
Figure 1.
Follow-up phone calls were completed in 84 patients (93%) with a median interval of 136 
days after the initial survey (range 115-185 days.) Of the 30 patients who initially reported 
that they were advised by their rheumatologist to seek further reproductive health care in the 
initial survey, only 3 patients did so at the follow-up call. Of the 84 who completed the 
follow-up call, 30 (36%) had concerns and questions about reproductive health over the past 
3 months. Twenty-one patients (25%) reported seeking further information about sex or 
reproductive health (since their initial visit) from family, internet, friends, school, other 
doctors, and the rheumatologist. Thirty-one patients (37%) reported seeking further 
information about their condition or medications (since their visit) from the internet, 
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rheumatologist, other doctors, family, and information packets. Fifteen patients (18%) 
reported having ever asked their rheumatology clinic provider for guidance regarding 
relationships or sex. Eight patients (10%) reported seeking additional reproductive or sexual 
health services since their visit at Planned Parenthood clinics, family doctors, gynecologists, 
and school clinics. Only one patient stated that she sought further care based on a 
rheumatologist's recommendation. Of the 8 patients who sought further reproductive health 
care, 7 were currently on high risk medications (OR 3.63, 95% CI 0.4 to 31.0.) See Figure 2 
for the distribution of patients who expressed health concerns at follow-up, and who actually 
sought care.
Discussion
This is the first study investigating patient perception of reproductive health counseling and 
its potential to effect behavior change in a pediatric rheumatology clinic. Our study indicates 
that a considerable proportion of teen rheumatology patients (42%) have recent reproductive 
health concerns but few necessarily follow through with a formal visit with a reproductive 
health care professional when counseled to do so. While teens do acknowledge counseling 
about reproductive health occurs during these physician-patient interactions, they may not 
have the know-how to obtain the necessary reproductive health services and interventions. 
This highlights the potential need for a different counseling tool, a formal referral process, 
or an additional intervention such as having a combined clinic with adolescent gynecology. 
Different settings may also be helpful to introduce the subject which may include having 
parents (mothers) be a part of the counseling process or a confidential peer session to review 
the information.
Patients taking high risk medications may require extra guidance compared to those not on 
high risk medications. For example, a new federal mandate in the United States requires that 
patients prescribed mycophenolate-containing compounds receive reproductive health 
counseling; however there are no specific guidelines for adolescent rheumatology patients. 
Changes in guidelines now recommend that screening by Papanicolau (Pap) test should not 
be used for women aged <21 years, regardless of initiation of sexual activity16. This may 
lower the barrier for pediatric rheumatologists who are comfortable in doing so to prescribe 
oral contraception and may reduce the need for more than annual gynecological exams from 
another provider. Making reproductive health discussion a routine process may help open 
communication and provide better understanding of patient motivation to seek further care. 
Training in core competencies of contraception counseling as a requirement in pediatric 
rheumatology fellowship is one way of implementing provider education, as well as 
potentially including it as a quality improvement initiative for maintenance of certification 
for rheumatology boards.
Study limitations
This study was limited by small sample size, its exclusion of males, and only enrolling 
English speaking families. Male patients do need counseling about reproductive health and 
may require a different intervention than females. Non-English speaking patients of 
Hispanic and Asian descent who comprise a significant proportion of patients at Stanford 
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may have different cultural beliefs than the studied population. Patients attending the clinic 
at Stanford reflect the demographics of Santa Clara County (which includes the city of San 
Jose), which has a higher median income and higher percentage of Asian and Hispanic 
populations than other major US cities. Our data may not be generalizable to other 
metropolitan centers with different demographics (e.g. more African-Americans or lower 
median incomes) that may have higher likelihood of sexual activity at a younger age but 
may also have different reproductive health seeking behaviors and resources. For the 
purposes of this study, data about sexual history, contraception, and information about 
fertility and gonadal protection were not collected but may be important variables in future 
research. Respondents potentially knew the interviewer conducting phone calls which could 
have influenced results as a way to please the investigator.
This observational study demonstrated the importance of reproductive health counseling in 
pediatric rheumatology. Future studies could include the development of a more 
standardized and effective counseling tool and referral process. There may also be a role for 
partnerships with other community service providers, such as adolescent clinics, to facilitate 
education and services, as well as trying to create a format to include other people in the 
conversation such as peers and/or parents to reinforce positive behaviors and follow through.
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Significance and Innovations
• This is the first study investigating patient perception of reproductive health 
counseling and subsequent follow up in a pediatric rheumatology clinic.
• Teen rheumatology patients are a high risk group for adverse reproductive 
health outcomes.
• Many teen rheumatology patients have recent reproductive health concerns.
• Few adolescent rheumatology patients follow through with a formal visit with a 
reproductive health care professional.
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Figure 1. Patient reproductive health seeking
Of the 30 patients who initially reported that they were advised by their rheumatologist to 
seek further reproductive health care in the initial survey; only 3 patients did so at follow-up. 
Two of those patients had said that they would plan to go in the future and one had said that 
they would definitely seek further care.
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Figure 2. Overlap of patients with reproductive health concerns who sought further care
At the initial visit, 30 patients were recommended to seek further reproductive health care. 
At follow-up, 3 of these patients actually sought further care while 20 still reported having 
reproductive health concerns.
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Table 1
Reproductive Health Counseling Tool
✓ Discussed need for contraception
✓ Recommended double barrier contraception if sexually active
✓ Discussed adolescents' right to confidential reproductive health care
✓ Risks of pregnancy in context of rheumatic disease
✓ Risks of potentially teratogenic medications:
✓ Need for planning prior to pregnancy in conjunction with medical provider
✓ What to do if worried about being pregnant
✓ Worries about future fertility
✓ Referred: □ Adolescent Medicine □ gynecologist □ PMD □ Planned Parenthood
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Table 2
Baseline patient characteristics
Patient Characteristics n %
Total 90
Age (SD) (yrs) 17 ± 2
Diagnosis
    JIA 41 45.6
    SLE/MCTD/Sjogren's 36 40
    Vasculitis 4 4.4
    Juvenile Dermatomyositis 3 3.3
    Scleroderma 2 2.2
    Other 4 4.4
    + Pain syndrome 15 16.7
Disease duration (SD) (yrs) 5 ± 4
Race/Ethnicity
    Non-Hispanic white 45 50
    Hispanic 22 24.4
    Asian/Pacific Islander 18 20
    Non-Hispanic black 3 3.3
    Unanswered 2 2.2
Insurance status
    Private 70 77.8
    Public 20 22.2
Medication use
    Remission off medications 5 5.6
    Current high risk medication use 61 67.8
    History of high risk medication use 74 82.2
Current high-risk medications
    biologics 21 23.3
    mycophenolate 17 18.9
    methotrexate 16 17.8
    azathioprine 11 12.2
    leflunomide 2 2.2
    cyclophosphamide 1 1.1
    tacrolimus 1 1.1
Development
    Post-menarchal 88 97.8
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